摘要
The price of Traditional Chinese Medicine （TCM） raw materials, such as radix pseudos- tellariae, hiked dramatically since 2010. More and more TCM companies feel more and more pressure in business： costs are up, and profits are down. In July 2011, Jiangzhong Pharmaceutical, a local TCM company, had to declare to raise the retail price for its two most popular TCM OCT, Jiangzhong Jianwei Xiaoshi Tablet （a digestion aid）, and Compound Sarcandra Glabra Tablet, even though the sales of digestion tablets had grown by nine times in 10 years.
Soaring prices of TCM raw materials The price of Traditional Chinese Medicine (TCM) raw materials, such as radix pseudostellariae, hiked dramatically since 2010. More and more TCM companies feel more and
